Schedule 13D ownership disclosure

BELLICUM PHARMACEUTICALS, INC

Security class unavailable · CUSIP: 079481404

Event date: 2023-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,197,919
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-056574
Form type
SC 13D
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
May 05, 2023
Reporting period
May 05, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub